CNS Pharmaceuticals, Inc. (CNSP)

CNS Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	12.13	6.46	0.55	10.06	5	14.04
Cash & Short-Term Investments	12.13	6.46	0.55	10.06	5	14.04
Cash Growth	713.24%	1077.53%	-94.54%	100.93%	-64.35%	93.88%
Other Receivables	-	0.88	-	-	-	-
Receivables	-	0.88	-	-	-	-
Prepaid Expenses	1.99	1.29	0.84	2.51	2.47	1.46
Other Current Assets	0.01	0.02	0.2	-	-	-
Total Current Assets	14.14	8.66	1.59	12.56	7.48	15.5
Property, Plant & Equipment	0	0.01	0	0.01	0.02	0.02
Long-Term Deferred Charges	-	-	-	-	0.33	0.33
Other Long-Term Assets	0.37	0.04	0.1	0.48	0.93	-
Total Assets	14.51	8.7	1.7	13.05	8.76	15.85
Accounts Payable	1.26	2.2	5.83	4.51	1.98	0.95
Accrued Expenses	-	-	-	-	0.22	0.52
Short-Term Debt	0.12	0.33	0.3	0.41	0.39	0.44
Total Current Liabilities	1.38	2.52	6.13	4.92	2.59	1.91
Total Liabilities	1.38	2.52	6.13	4.92	2.59	1.91
Common Stock	0	0	0	0	0	0.02
Additional Paid-In Capital	104.23	90.6	65.13	58.85	41.6	34.87
Retained Earnings	-91.1	-84.42	-69.57	-50.72	-35.44	-20.95
Shareholders' Equity	13.12	6.18	-4.43	8.13	6.16	13.95
Total Liabilities & Equity	14.51	8.7	1.7	13.05	8.76	15.85
Total Debt	0.12	0.33	0.3	0.41	0.39	0.44
Net Cash (Debt)	12.01	6.14	0.25	9.65	4.62	13.6
Net Cash Growth	777.59%	2374.76%	-97.43%	108.92%	-66.05%	87.81%
Net Cash Per Share	66.34	192.61	-	-	-	-
Filing Date Shares Outstanding	0.57	0.25	-	-	-	-
Total Common Shares Outstanding	0.5	0.12	-	-	-	-
Working Capital	12.75	6.13	-4.54	7.64	4.88	13.59
Book Value Per Share	26.02	52.43	-	-	-	-
Tangible Book Value	13.12	6.18	-4.43	8.13	6.16	13.95
Tangible Book Value Per Share	26.02	52.43	-	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q